相关实验视频
Updated: Jul 11, 2025

09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
392
阻止转移的道:针对乳腺癌中的运输
William J Brackenbury1,2, Carlo Palmieri3,4
1Department of Biology, University of York, Wentworth Way, Heslington, York, YO10 5DD, UK. william.brackenbury@york.ac.uk.
Breast cancer research : BCR
|November 11, 2023
概括
局部麻醉剂利多卡因通过阻断电压导入通道 (VGSCs) 改善了乳腺癌患者的无疾病生存率. 这表明VGSC抑制剂可以被重新定位为新型抗转移药物.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 转移是乳腺癌治疗的一个主要挑战,需要新的抗转移疗法.
- 电压通道 (VGSCs) 与癌细胞入侵和转移有关.
- 临床前研究和观察数据表明VGSC抑制剂可能具有抗癌作用.
研究的目的:
- 评估手术前注射利多卡因在改善乳腺癌患者无病生存期 (DFS) 的疗效.
- 探索电压通道 (VGSC) 抑制剂作为抗转移药物的潜力.
主要方法:
- 一个开放的,多中心的随机试验.
- 术前,周注射利多卡因,一种阻断VGSCs的局部麻醉剂.
- 评估无病生存 (DFS) 作为主要终点.
主要成果:
- 接受利多卡因治疗的乳腺癌患者在无病生存率 (DFS) 中显著改善.
- 利多卡因的机制涉及阻断电压通道 (VGSCs),这些通道对于癌细胞入侵至关重要.
- 这项研究支持VGSCs在驱动癌症转移中的作用.
结论:
- 手术前给予利多卡因提供了一种潜在的治疗策略,以改善乳腺癌中DFS.
- 重用现有的VGSC抑制剂为开发新型抗转移疗法提供了一个有希望的途径.
- 需要进一步的研究来研究其他VGSC抑制剂和用于癌症治疗的离子通道.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Secondary Active Transport
7.1K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Antihypertensive Drugs: Potassium-Sparing Diuretics
589
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
589
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
170
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
170

